Medicago sativa Extracts Enhance the Anticancer Efficacy of GEM in PANC-1 Cells through Apoptosis Induction and
Nazanin Jamshidi1, Negar Jamshidi1, Mohammad Zaman2
1Kimia Andisheh Teb, Medical and Molecular Laboratory Research Co., Tehran, Iran.
Introduction:
Pancreatic cancer (PC) has a poor prognosis and limited response to therapies. Combinatorial approaches, such as natural product-based therapies, can enhance anticancer efficacy while minimizing side effects. This study evaluated M. sativa's anticancer properties and its potential as adjunctive therapy with Gemcitabine (GEM) to sensitize PANC-1 cells to chemotherapy.
Methods:
The antioxidant activity (AA) and total phenolic content (TPC) of M. sativa extracts (Methanol, Ethyl acetate, and water) were assessed using the DPPH radical scavenging assay. Cytotoxic effects on PANC1 and HUVEC cells were also evaluated by utilizing the MTT assay. Then, apoptosis detection was performed by Annexin V/PI-flow cytometry (FC). Besides, the DNA fragmentation analysis was conducted utilizing agarose gel electrophoresis (AGE). Bcl-2, Bax, and CASP3 expression levels in PANC-1 cells using western blot analysis and qRT-PCR.
Results:
Herein, DPPH IC50 values for M. sativa extracts (water, MeOH, EtOH) were 76.21, 110.32, and 65.39 μg/ml, respectively. The water extract of M. sativa exhibited the highest TPC (4612.15 ± 119.4 mgGAE/g). The cytotoxicity IC50 values for EtOH M. sativa extract, GEM, and combined GEM with EtOH M. sativa on PANC1 cells were 68.74, 43.53, and 41.22 µg/ml M. sativa + 25 µg/ml GEM, respectively, with no toxicity observed in HUVEC cells. FC analysis revealed that Combining GEM and EtOH M. sativa yielded the highest apoptosis rate (25.6%). Expression changes in Bcl-2, Bax, and CASP3, as well as morphological alterations and DNA fragmentation, indicated apoptotic cell death.
Conclusion:
Our findings suggested that combining M.sativa EtOH extracts with GEM may represent a promising strategy for treating PC.
Insights
This study shows that combining M. sativa ethanol extract with Gemcitabine (GEM) enhances pancreatic cancer cell death. This natural product combination therapy offers a promising approach for treating pancreatic cancer.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Pancreatic cancer (PC) presents a significant clinical challenge due to its poor prognosis and limited therapeutic options.
- Combinatorial therapies, particularly those incorporating natural products, are being explored to improve efficacy and reduce side effects.
- This research investigates the potential of Medicago sativa (M. sativa) as an adjunct to Gemcitabine (GEM) chemotherapy for PANC-1 pancreatic cancer cells.
Purpose of the Study:
- To evaluate the anticancer properties of M. sativa extracts.
- To determine if M. sativa can sensitize PANC-1 cells to Gemcitabine (GEM).
- To assess the safety of M. sativa and GEM combination therapy on normal cells.
Main Methods:
- Assessed antioxidant activity and total phenolic content of M. sativa extracts using DPPH and spectrophotometric assays.
- Evaluated cytotoxicity of extracts and GEM on PANC-1 and HUVEC cells via MTT assay.
- Analyzed apoptosis induction using flow cytometry, DNA fragmentation assays, and Western blot/qRT-PCR for apoptosis-related gene expression (Bcl-2, Bax, CASP3).
Main Results:
- M. sativa water extract showed the highest total phenolic content.
- The combination of M. sativa EtOH extract and GEM demonstrated enhanced cytotoxicity against PANC-1 cells compared to GEM alone, with no observed toxicity in HUVEC cells.
- Combination therapy significantly increased apoptosis rates and induced characteristic apoptotic cell death markers, including DNA fragmentation and altered expression of Bcl-2, Bax, and CASP3.
Conclusions:
- M. sativa ethanol extract shows potential as a sensitizing agent for pancreatic cancer chemotherapy.
- The combination of M. sativa EtOH extract with Gemcitabine (GEM) presents a promising adjunctive therapeutic strategy for pancreatic cancer.
- Further research into this natural product-based combinatorial approach is warranted for pancreatic cancer treatment.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
09:56Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment
Published on: April 30, 2019
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
